Literature DB >> 15252316

Current practical applications of diagnostic immunohistochemistry in breast pathology.

Melinda F Lerwill1.   

Abstract

In recent years, immunohistochemistry has assumed an increasingly prominent role in diagnostic breast pathology. Immunohistochemistry is now frequently used in the evaluation of many epithelial proliferations of the breast. Common applications include the use of myoepithelial markers to evaluate for stromal invasion, E-cadherin to distinguish between ductal and lobular neoplasia, high molecular weight cytokeratins to differentiate usual ductal hyperplasia from ductal carcinoma in situ, immunohistochemical profiles to characterize site of origin of metastatic carcinomas, and cytokeratin stains to detect metastases in sentinel lymph nodes. Recent advances, practical considerations, and potential pitfalls in the use of immunohistochemistry in these five diagnostic categories are discussed herein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252316     DOI: 10.1097/01.pas.0000126780.10029.f0

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  30 in total

1.  Small-cell neuroendocrine carcinoma of the breast.

Authors:  W D Salman; J A F Harrison; A J Howat
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

2.  Regression of ductal carcinoma in situ after treatment with acupuncture.

Authors:  Regina Dehen
Journal:  J Altern Complement Med       Date:  2013-03-28       Impact factor: 2.579

3.  Invasive ductal carcinoma with in situ pattern: how to avoid this diagnostic pitfall?

Authors:  Narasimhamurthy Mohan; Jennifer O Black; Mary R Schwartz; Qihui Jim Zhai
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

4.  CD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer Progression.

Authors:  Jeanne M V Louderbough; Jessie A Brown; Ray B Nagle; Joyce A Schroeder
Journal:  Genes Cancer       Date:  2011-08

Review 5.  Cellular mechanisms regulating epithelial morphogenesis and cancer invasion.

Authors:  Ryan S Gray; Kevin J Cheung; Andrew J Ewald
Journal:  Curr Opin Cell Biol       Date:  2010-09-09       Impact factor: 8.382

6.  Regulation of in situ to invasive breast carcinoma transition.

Authors:  Min Hu; Jun Yao; Danielle K Carroll; Stanislawa Weremowicz; Haiyan Chen; Daniel Carrasco; Andrea Richardson; Shelia Violette; Tatiana Nikolskaya; Yuri Nikolsky; Erica L Bauerlein; William C Hahn; Rebecca S Gelman; Craig Allred; Mina J Bissell; Stuart Schnitt; Kornelia Polyak
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

7.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

8.  Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Authors:  Julio E Celis; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans-Wielenga; Fritz Rank; José M A Moreira
Journal:  Mol Oncol       Date:  2007-09-25       Impact factor: 6.603

9.  Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization.

Authors:  Xiu Nie; Jun He; Yan Li; Dan-Zhen Pan; Hua-Xiong Pan; Mi-Xia Weng; Xiu-Ping Yang; Chun-Ping Liu; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

10.  Encapsulated apocrine papillary carcinoma of the breast--a tumour of uncertain malignant potential: report of five cases.

Authors:  Melanie Seal; Christine Wilson; Gregory J Naus; Stephen Chia; Terry C Bainbridge; Malcolm M Hayes
Journal:  Virchows Arch       Date:  2009-10-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.